Re: Breast Cancer Test Wins FDA Clearance

From: art fougner, md (evsono@pipeline.com)
Wed Jan 9 15:36:20 2002


Marilyn -

this was written up awhile back - am glad it is coming to fruition - the concept makes sense - detect a population at high risk and then treat. we all know that the sensitivity of mammography leaves much to be desired. still premature to be ecstatic but this is very encouraging news.

just my opinion - i could be wrong.

art

art

At Wed, 09 Jan 2002, Marilyn Ringst wrote: >
>Breast Cancer Test Wins FDA Clearance
>
> The device was developed with the goal of better
> enabling physicians to detect atypical changes
> in cells lining the milk ducts, which is where
> an estimated 95 percent of all breast cancers
> originate, according to the company.
>
>http://www.medicaldata.com/mit/detail.asp?art=01090205&MITUID=216694
>

>--

--

art fougner, md ich bin ein New Yorker





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 04:50:51 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.